These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 39084474)
1. Metabolic control of collagen synthesis. Guillard J; Schwörer S Matrix Biol; 2024 Nov; 133():43-56. PubMed ID: 39084474 [TBL] [Abstract][Full Text] [Related]
2. Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis. Rønnow SR; Dabbagh RQ; Genovese F; Nanthakumar CB; Barrett VJ; Good RB; Brockbank S; Cruwys S; Jessen H; Sorensen GL; Karsdal MA; Leeming DJ; Sand JMB Respir Res; 2020 May; 21(1):108. PubMed ID: 32381012 [TBL] [Abstract][Full Text] [Related]
3. Three dimensional fibrotic extracellular matrix directs microenvironment fiber remodeling by fibroblasts. Nizamoglu M; Alleblas F; Koster T; Borghuis T; Vonk JM; Thomas MJ; White ES; Watson CK; Timens W; El Kasmi KC; Melgert BN; Heijink IH; Burgess JK Acta Biomater; 2024 Mar; 177():118-131. PubMed ID: 38350556 [TBL] [Abstract][Full Text] [Related]
4. The good and the bad collagens of fibrosis - Their role in signaling and organ function. Karsdal MA; Nielsen SH; Leeming DJ; Langholm LL; Nielsen MJ; Manon-Jensen T; Siebuhr A; Gudmann NS; Rønnow S; Sand JM; Daniels SJ; Mortensen JH; Schuppan D Adv Drug Deliv Rev; 2017 Nov; 121():43-56. PubMed ID: 28736303 [TBL] [Abstract][Full Text] [Related]
5. The role of metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer. Hamanaka RB; Mutlu GM Amino Acids; 2021 Dec; 53(12):1851-1862. PubMed ID: 33963932 [TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase M2 regulates fibrosis development and progression by controlling glycine auxotrophy in myofibroblasts. Satyanarayana G; Turaga RC; Sharma M; Wang S; Mishra F; Peng G; Deng X; Yang J; Liu ZR Theranostics; 2021; 11(19):9331-9341. PubMed ID: 34646373 [No Abstract] [Full Text] [Related]
7. mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β Selvarajah B; Azuelos I; Platé M; Guillotin D; Forty EJ; Contento G; Woodcock HV; Redding M; Taylor A; Brunori G; Durrenberger PF; Ronzoni R; Blanchard AD; Mercer PF; Anastasiou D; Chambers RC Sci Signal; 2019 May; 12(582):. PubMed ID: 31113850 [TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart. Miller CL; Cai Y; Oikawa M; Thomas T; Dostmann WR; Zaccolo M; Fujiwara K; Yan C Basic Res Cardiol; 2011 Nov; 106(6):1023-39. PubMed ID: 22012077 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronan's Role in Fibrosis: A Pathogenic Factor or a Passive Player? Albeiroti S; Soroosh A; de la Motte CA Biomed Res Int; 2015; 2015():790203. PubMed ID: 26583132 [TBL] [Abstract][Full Text] [Related]
10. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Cox TR; Erler JT Dis Model Mech; 2011 Mar; 4(2):165-78. PubMed ID: 21324931 [TBL] [Abstract][Full Text] [Related]
11. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts. Cho N; Razipour SE; McCain ML Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479 [TBL] [Abstract][Full Text] [Related]
12. Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy. Zhou L; Liang Q; Li Y; Cao Y; Li J; Yang J; Liu J; Bi J; Liu Y Acta Biomater; 2022 Oct; 152():235-254. PubMed ID: 36087869 [TBL] [Abstract][Full Text] [Related]
14. A strategic expression method of miR-29b and its anti-fibrotic effect based on RNA-sequencing analysis. Fan X; Gao Y; Zhang X; Lughmani HY; Kennedy DJ; Haller ST; Pierre SV; Shapiro JI; Tian J PLoS One; 2020; 15(12):e0244065. PubMed ID: 33332475 [TBL] [Abstract][Full Text] [Related]
15. Collagenase Type I and Probucol-Loaded Nanoparticles Penetrate the Extracellular Matrix to Target Hepatic Stellate Cells for Hepatic Fibrosis Therapy. Wang X; Zhang W; Zeng S; Wang L; Wang B Acta Biomater; 2024 Feb; 175():262-278. PubMed ID: 38141933 [TBL] [Abstract][Full Text] [Related]
16. Targeting collagen for diagnostic imaging and therapeutic delivery. Wahyudi H; Reynolds AA; Li Y; Owen SC; Yu SM J Control Release; 2016 Oct; 240():323-331. PubMed ID: 26773768 [TBL] [Abstract][Full Text] [Related]
17. CTHRC1: An Emerging Hallmark of Pathogenic Fibroblasts in Lung Fibrosis. Mukhatayev Z; Adilbayeva A; Kunz J Cells; 2024 May; 13(11):. PubMed ID: 38891078 [TBL] [Abstract][Full Text] [Related]
18. Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges. Luangmonkong T; Parichatikanond W; Olinga P Biochem Pharmacol; 2023 Sep; 215():115740. PubMed ID: 37567319 [TBL] [Abstract][Full Text] [Related]
19. Three distinct cell populations express extracellular matrix proteins and increase in number during skeletal muscle fibrosis. Chapman MA; Mukund K; Subramaniam S; Brenner D; Lieber RL Am J Physiol Cell Physiol; 2017 Feb; 312(2):C131-C143. PubMed ID: 27881411 [TBL] [Abstract][Full Text] [Related]
20. Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target. Schimmel K; Ichimura K; Reddy S; Haddad F; Spiekerkoetter E Front Cardiovasc Med; 2022; 9():886553. PubMed ID: 35600469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]